Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotypic HIV-1 tropism in proviral DNA to guide maraviroc in virologically suppressed patients
2011-000799-32Phase 4Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoint: Sustained virologic suppression at 48 weeks. Started Nov 2011; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2011-000799-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000799-32.